Skip to main content
Debate: Optimal Treatment for HER2-Positive Colorectal Cancer After First-Line Treatment: Chemotherapy or HER2-Positive Agents? Chemotherapy.
Thursday, October 28, 2021
12:50 PM – 12:58 PM
Aparna Kalyan, MD, MBBS
Northwestern Medicine, Feinberg School of Medicine
This talk is supported by educational grants provided by Bayer HealthCare Pharmaceuticals, Inc., Pfizer
Inc. and Taiho Oncology, Inc.